Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen

L J Wheat1, P Connolly-Stringfield, R Blair

  • 1Department of Internal Medicine, Indiana University, Indianapolis 46202.

Annals of Internal Medicine
|December 15, 1991
PubMed
Abstract

Insights

An increase in Histoplasma capsulatum polysaccharide antigen levels strongly suggests histoplasmosis relapse in AIDS patients. This antigen test is more accurate than complement fixation titers for diagnosing relapse.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunology

Background:

  • Histoplasmosis is a significant opportunistic infection in patients with acquired immunodeficiency syndrome (AIDS).
  • Accurate identification of histoplasmosis relapse is crucial for effective patient management and preventing mortality.
  • Current diagnostic methods for relapse may have limitations in sensitivity and specificity.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of Histoplasma capsulatum variety capsulatum polysaccharide antigen testing for identifying histoplasmosis relapse.
  • To compare the utility of antigen testing with complement fixation titers in detecting relapse.

Main Methods:

  • A retrospective study analyzing stored serum and urine specimens from patients with AIDS.
  • Inclusion of 20 relapse episodes in 17 patients and control groups of patients without relapse.
  • Standardized radioimmunoassay used for H.c. var. capsulatum polysaccharide antigen detection to ensure consistency.

Main Results:

  • Elevated H.c. var. capsulatum antigen levels (≥2 units) were observed in 85.7% of serum and 94.4% of urine specimens during relapse.
  • High specificity (98.2%) was achieved, with minimal antigen level increases in control groups.
  • Antigen levels increased prior to clinical suspicion of relapse in three instances.

Conclusions:

  • A ≥2 unit increase in H.c. var. capsulatum polysaccharide antigen levels is a strong indicator of histoplasmosis relapse in AIDS patients.
  • Antigen testing demonstrates superior accuracy for diagnosing relapse compared to complement fixation antibody titers.